IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 247 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,409 | -25.1% | 216 | 0.0% | 0.00% | – |
| Q1 2024 | $1,882 | -23.9% | 216 | 0.0% | 0.00% | -100.0% |
| Q4 2023 | $2,472 | +18.8% | 216 | 0.0% | 0.00% | – |
| Q3 2023 | $2,081 | -31.4% | 216 | -24.2% | 0.00% | -100.0% |
| Q2 2023 | $3,033 | +101.5% | 285 | +99.3% | 0.00% | – |
| Q1 2023 | $1,505 | -13.9% | 143 | +1.4% | 0.00% | – |
| Q4 2022 | $1,747 | +74.7% | 141 | -1.4% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 143 | +53.8% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 93 | +89.8% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 49 | -44.3% | 0.00% | – |
| Q3 2021 | $1,000 | – | 88 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $183,240,000 | 17.56% |
| HealthInvest Partners AB | 1,450,000 | $16,211,000 | 12.91% |
| Healthcare Value Capital, LLC | 200,000 | $2,236,000 | 4.98% |
| BRIDGER MANAGEMENT, LLC | 2,852,414 | $31,890,000 | 2.98% |
| Camber Capital Management LP | 7,500,000 | $83,850,000 | 2.88% |
| 13D Management LLC | 658,017 | $7,357,000 | 2.72% |
| Brown Capital Management | 20,170,126 | $225,502,000 | 1.68% |
| Healthcare Value Capital, LLC | 50,000 | $559,000 | 1.24% |
| Zebra Capital Management LLC | 59,122 | $661,000 | 0.73% |
| PRICE MICHAEL F | 520,000 | $5,814,000 | 0.70% |